Oral contraceptives are used by tens of millions of women each year. The FDA issued an October 2008 warning letter to Bayer to pull misleading ads that overstated the efficacy of the contraceptive drugs Yaz™, Yasmin™ and Ocella™. The ads, the FDA warned, also minimized the risks associated with those drugs.
Yaz™, Yasmin™ and Ocella™ (the generic form of the drug) all contain drospireone, which other oral contraceptives do not. Research shows that drospirenone leads to a higher risk of blood clots. These blood clots may lead to such adverse health effects as heart attack, stroke and the development of pulmonary embolism. Use of Yaz™, Yasmin™, or Ocella™ may also lead to gallbladder disease and pancreatitis.
- Deep Vein Thrombosis
- Pulmonary Embolism
- Heart Attack
- Gallbladder Removal
- Kidney Failure
- Pancreatic Cancer
Thousands of lawsuits are currently pending against Bayer™. If you or a loved one has suffered the side effects listed above and you that suspect Yaz™, Yasmin™ or Ocella™ may have been the cause, please contact our office immediately.
Let the experienced professionals of Inserra, Kelley & Sewell stand with you to protect your right to fair treatment and fair compensation.